This is the authors' abstract. We don't add key points for this paper.
The strategic incorporation of the pharmacologically privileged trifluoroethyl group into the biologically significant benzofuran scaffold offers considerable potential for medicinal and agrochemical applications. Herein, an atom‐economical synthetic approach to 3‐trifluoroethyl benzofurans through Rh‐catalyzed cascade reaction of readily available trifluoromethyl alkene‐tethered benzocyclobutenols is reported. This transformation proceeds via a mechanistically intricate sequence involving CC bond activation, migratory insertion, β ‐hydride elimination, chain walking, and transfer hydrogenation. By modulation of reaction conditions, both intermolecular and intramolecular transfer hydrogenation pathways have been developed, leading to the divergent synthesis of 4‐ β ‐keto‐ and 4‐ β ‐hydroxy‐substituted 3‐trifluoroethyl benzofurans.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: